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Abstract
Staphylococcus epidermidis (SE) causes late onset sepsis and significant morbidity in catheterized preterm newborns. Animal
models of SE infection are useful in characterizing disease mechanisms and are an important approach to developing
improved diagnostics and therapeutics. Current murine models of neonatal bacterial infection employ intraperitoneal or
subcutaneous routes at several days of age, and may, therefore, not accurately reflect distinct features of innate immune
responses to bacteremia. In this study we developed, validated, and characterized a murine model of intravenous (IV)
infection in neonatal mice ,24 hours (h) old to describe the early innate immune response to SE. C57BL/6 mice ,24 h old
were injected IV with 10
6,1 0
7,1 0
8 colony-forming units (CFU) of SE 1457, a clinical isolate from a central catheter infection.
A prospective injection scoring system was developed and validated, with only high quality injections analyzed. Newborn
mice were euthanized between 2 and 48 h post-injection and spleen, liver, and blood collected to assess bacterial viability,
gene expression, and cytokine production. High quality IV injections demonstrated inoculum-dependent infection of
spleen, liver and blood. Within 2 h of injection, SE induced selective transcription of TLR2 and MyD88 in the liver, and
increased systemic production of plasma IL-6 and TNF-a. Despite clearance of bacteremia and solid organ infection within
48 h, inoculum-dependent impairment in weight gain was noted. We conclude that a model of IV SE infection in neonatal
mice ,24 h old is feasible, demonstrating inoculum-dependent infection of solid organs and a pattern of bacteremia, rapid
and selective innate immune activation, and impairment of weight gain typical of infected human neonates. This novel
model can now be used to characterize immune ontogeny, evaluate infection biomarkers, and assess preventative and
therapeutic modalities.
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Introduction
Human neonates express a distinct, but incompletely charac-
terized, immune response to infection. This response is heavily
dependent on innate immunity due to early qualitative and
quantitative deficiencies in the adaptive immune system [1,2].
Innate immune function is itself dependent on both gestational
and postnatal age, and is essential for host defense against infection
[2,3,4]. Accordingly, preterm newborns are particularly suscepti-
ble to invasive bacteria. In addition to this age-dependent activity,
neonatal immune responses rely heavily on the expression of
pattern recognition receptors such as Toll-like receptors (TLRs)
[2,5,6]. Notably, there is a specific pattern of TLR-mediated
cytokine production by neonatal mononuclear cells, monocytes
and antigen-presenting cells that is skewed toward low production
of pro-inflammatory Th1-polarizing cytokines (e.g., TNF-a) and
high production of cytokines with anti-inflammatory or Th2-
polarizing activities (e.g., IL-6) [2,3,7,8,9,10,11]. A number of
recent studies have shed light on the distinct responses of newborns
to TLR agonists in vitro [12,13], but much remains to be learned
regarding interactions of the newborn with live bacterial
pathogens in vivo.
Staphylococcus epidermidis (SE) is the most common cause of late
onset sepsis in neonatal intensive care units worldwide and
disproportionately affects preterm newborns [14,15,16,17,18]. SE
expresses multiple virulence factors, including those that enhance
biofilm formation and resist phagocytic killing [19]. SE also
releases soluble factors that activate host cells via TLR2
[19,20,21]. Although SE infection results in relatively low case
mortality (,2%), it is associated with significant long-term
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e43897morbidity, especially among infants ,30 weeks gestation,
prolonging length of hospitalization and significantly increasing
health care costs [14,15,22]. Recent epidemiologic data suggest
that sepsis due to Gram-positive bacteria may be associated with
neurodevelopmental impairment and poor long-term neurodevel-
opmental outcomes [15,23,24,25,26]. Therefore, there is an
unmet medical need to prevent and enhance treatment of SE
infection [27]. In this context, preclinical animal infection models
are a key approach to characterize host-pathogen interactions and
inform development of novel biomarkers and anti-infective agents
[28]. Several newborn mouse models of staphylococcal infection
have been described. However, these have largely focused on mice
2 to 7 days of age and employed either intra-peritoneal or
subcutaneous routes of infection [29,30,31,32,33,34,35]. Addi-
tionally, while lymphoid organ development and immunity in
mice at 7 days is comparable to term human neonates, there is
little information regarding the ontogeny of the mouse immune
system early enough to compare to human preterms [3,36].
Because age and route of infection can play fundamental roles in
both risk of infection and immune responses to SE [37,38], we
sought to develop a model in newborn mice ,24 h old via the IV
route.
Herein, we report a novel approach to characterize neonatal
host-pathogen interactions by establishing a neonatal model of IV
SE infection in mice ,24 h old that demonstrates both inoculum-
dependent infection of blood and solid organs and activation of
innate immune responses. Using this novel model, we demonstrate
that in response to SE bacteremia, newborn mice rapidly and
selectively up-regulate transcription of TLR2 and MyD88, and
mount a systemic cytokine response. Although these early innate
immune responses are associated with clearance of SE infection,
this host-pathogen interaction results in impairment of weight
gain, an important marker of neonatal well-being [30,39,40].
Methods
Ethics Statement
All animal protocols were approved by the Animal Care and
Use Committee of Boston Children’s Hospital (11-11-2076R).
Bacteria
Our studies utilized SE 1457, a clinical strain from an adult
patient with a central catheter infection that was previously
isolated by Mack and colleagues [41]. Of note, SE 1457 expresses
multiple virulence factors, including biofilm forming compounds
(poly-c-glutamic acid), polysaccharide intercellular adhesins, and
phenol soluble modulins [19,42].
Preparation of Inoculum
500 ml of bacterial stock were added to 30 ml trypticase soy
broth (TSB) in a 125 ml baffled flask. Bacteria were grown for 16–
20 h in an incubator/shaker at 37uC and 240 RPM. Following
overnight incubation, a 1:20 dilution of the starter stock was made
in a 5 ml TSB tube and optical density (OD) was measured at
600 nm. The requisite volume of bacteria, based upon an SE
density factor of 0.68610
9 (SE/ml) per OD, was harvested by
centrifugation at 30006G for 5 minutes at 4uC. The pellet was
resuspended in 1 ml of sterile, pyrogen-free saline (Baxter
Healthcare Corp, Deerfield, IL). Serial dilutions in saline yielded
bacterial concentrations of 2610
7,2 610
8, and 2610
9 SE/ml,
such that a 50 ml dose contained 10
6,1 0
7,1 0
8 SE.
Mice
C57BL/6 mice were obtained from Jackson Laboratory (Bar
Harbor, ME) and housed in the animal research facilities at
Boston Children’s Hospital. All procedures were in accordance
with an IACUC–approved animal protocol.
Bacteremia Model
Mouse pups ,24 h old were used for all experiments. Gravid
dams were monitored on a daily basis during the expected week of
parturition to confirm age of pups. Additionally, age was verified
using pup appearance (newborns were pink with translucent skin)
[43] and weight at the time of the experiment. Pups were injected
via the intra-jugular route with 50 ml of either saline or 10
6,1 0
7,o r
10
8 CFUs of SE. Dose range was selected based on experiments
demonstrating systemic cytokine responses (e.g., IL-6) at those
doses. This range was also consistent with bacterial inocula
reported in other murine models [30,44]. Injections utilized a two-
person technique adapted from Kienstra et al (Table 1, Video S1)
[45]. One investigator restrained each pup by pinning their right
forelimb to their body with thumb and extending their neck with
index finger to expose the external jugular vein on the right side
(Figure 1A, B). A second investigator then approached the external
jugular vein at a 10–20 degree angle (Figure 1C), inserted needle
and delivered the inoculum (Figure 1D). Following injection, the
first investigator provided pressure for hemostasis at the site of
injection (Figure 1E), monitored for signs of distress, and marked
pups for future identification. Both investigators then determined
an injection score based on a previously validated scoring scale
(Table 2). Only injections with scores of 3 or greater were included
in subsequent analyses (Figure 2). After several months of training,
investigators routinely achieved high quality injections (scores of
3–5) on ,70–80% of pups. Following injections, mice were
returned to their cage and left for a predetermined time interval of
2, 24, or 48 h. At the indicated time-points, pups were weighed
and sacrificed via decapitation or terminal cardiac puncture for
organ extraction, bacterial culture and cytokine profiling.
Bacterial Recovery from Murine Organs and Immunologic
Response to Infection
To ensure maximal sterility, work surfaces and instruments were
cleaned with 70% ethanol and RNAse Zap (Applied Biosystems/
Ambion, Austin, TX). At a predetermined time-point, mice were
either sacrificed via decapitation or cardiac puncture. Cardiac
puncture was performed following the technique outlined by Hoff
et al [46]. 20–30 ml of blood were collected and placed in 5 ml
pyrogen-free heparin sodium (1,000 USP units/ml; Sagent
Pharmaceuticals, Schaumburg, IL) on ice for cytokine analyses
and quantification of bacterial growth. To expose the abdominal
contents, a transverse incision was made through the skin at the
level of the umbilicus. Similarly, a vertical incision was made
starting at the umbilicus toward the diaphragm. Spleen and liver
were identified in the left and right upper quadrants of the
abdominal cavity, respectively. The spleen was dissected away
from the stomach with forceps and placed into a 1.7 ml
microcentrifuge tube containing 2.5 mm glass beads (Biospec
Products, Inc, Bartlesville, OK) up to the 1 ml line and 780 mlo f
saline. The multi-lobed liver was removed by clipping its fascial
connection to the diaphragm and then dividing into two equal
halves. One half was prepared for culture in the same manner as
the spleen while the other was placed in one volume of RNAlater
(QIAGEN, Valencia, CA) for gene expression studies. Tubes
containing spleen and liver tissue were homogenized using a Mini-
Beadbeater-16 (Biospec Products, Inc) for 1 minute. Tissue
Neonatal Mouse Model of IV SE Infection
PLOS ONE | www.plosone.org 2 September 2012 | Volume 7 | Issue 9 | e43897homogenates were then prepared for plating at mulitple dilutions
(spleen at neat, 1:10, and 1:100; liver at 1:10, 1:100, and 1:1000) to
ensure CFUs were accurately counted. Dilutions were made with
sterile saline. 50 ml samples were plated onto Trypticase soy agar
(TSA) with 5% sheep blood plates (BD Diagnostics, Franklin
Lakes, NJ) and placed in an incubator at 37uC with 5% CO2 for
16–24 h. Liver halves placed in RNAlater solution were stored at
220uC. Mice were weighed pre-injection and immediately prior
to decapitation/cardiac puncture to assess percent weight change
following SE challenge.
Purification of mouse liver RNA for gene expression
analysis
All pipettes/surfaces were cleaned with RNase Zap to prevent
degradation of RNA. Liver RNA samples were preserved in
RNAlater and stored at 220uC. RNA was isolated using the
RNeasy Mini Kit and RNeasy MinElute Cleanup Kit, per the
manufacturer’s instructions (QIAGEN). RNA concentration and
purity were measured using a Nanodrop 1000 spectrophotometer
(Thermo Fisher Scientific, DE).
Quantitative real time PCR (qRT-PCR) for gene expression
analysis
Expression levels of selected genes were assessed by qRT-PCR
analysis using an ABI 7300 real-time PCR system and software
(Applied Biosystems, Foster City, CA). mRNA (100 ng) was
reverse-transcribed to cDNA using the RT
2 First Strand Kit
(QIAGEN) according to the manufacturer’s instructions. The
equivalent of approximately 1 ng RNA/well was assayed using the
RT
2 Profiler PCR Array System according to the manufacturer’s
instructions. We utilized a Mouse Toll-like Receptor Signaling
PCR Array (PAMM-018, QIAGEN) containing primers for 84
genes of interest and 12 controls. Controls included 5 housekeep-
ing genes (glucuronidase beta, hypoxanthine guanine phosphor-
ibosyl transferase, heat shock protein 90 alpha [cytosolic] class B
member 1, glyceraldehyde-3-phosphate dehydrogenase, and actin
beta), mouse genomic DNA contamination-, 2 reverse transcrip-
tion-, and 2 positive PCR controls. mRNA levels were normalized
to housekeeping genes and quantified using the DD comparative
threshold (Ct) method using the analysis tools provided by
QIAGEN (http://www.sabiosciences.com/pcr/arrayanalysis.
php).
Cytokine Quantification
Plasma IL-6 and TNF-a were determined by ELISA as per the
manufacturer’s instructions (eBioscience, San Diego, CA, USA).
Additionally, a panel of mouse cytokine and chemokines (TNF-a,
MCP-1, IL-6, KC, IL-12 (p70), G-CSF, GM-CSF, IL-10, IL-1b,
and IPL-10) were measured in diluted heparinized plasma, using
Figure 1. Intrajugular injection of SE in mice less than 24 h old. A) Depiction of murine anatomy including the ventral muscles and blood
vessels of the neck, highlighting the location of the external jugular vein (image used with permission of Nature Publishing Group). B) Positioning of
mouse and exposure of neck for injection into right external jugular vein. C) Insertion of needle into external jugular vein. D) Injection of inoculum
into external jugular vein. E) Removal of needle showing blood return following vessel puncture.
doi:10.1371/journal.pone.0043897.g001
Figure 2. Induction of bacteremia is proportional to injection
scoring criteria. Newborn mice less than 24 h old were injected with
10
8 CFU of SE. Mice were euthanized, organs harvested, and CFUs
measured. CFU data were stratified by injection score, determined as
per Table 2. Prospective injection scores of 3 or higher correlated with
substantially greater CFUs in mouse spleen and liver (N=5–8,
** p,0.01, *** p,0.001, Mann-Whitney t-test).
doi:10.1371/journal.pone.0043897.g002
Neonatal Mouse Model of IV SE Infection
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noassay Kit (Millipore, Chicago, IL). Data were acquired on a
Milliplex Analyzer Luminex 100 machine and analyzed using
xPonent 3.1 software (Millipore) according to the manufacturer’s
instructions.
Genetic analyses
Samples of mouse tail tissue were genotyped for XX vs. XY
using real time PCR by Transnetyx (Cordova, TN).
Statistical Analyses
Statistical analyses of mRNA expression employed commer-
cially available on-line software (QIAGEN) using a Student’s t-test
of the replicate 2
2DCt values for each gene in the control and test
groups. Graphpad Prism 5.0a Software (San Diego, CA) was used
to perform all statistical analyses. Unless otherwise stated, all data
were based on experiments with injection scores $3. Data groups
with unequal variances were analyzed using a Mann-Whitney
unpaired t-test. A lower limit of detection of 50 CFU/ml was
determined and used for statistical analyses. P-values,0.05 were
considered significant.
Results
Feasibility of a newborn IV SE infection model
We developed a novel model of IV SE infection in newborn
mice less than 24 h old, incorporating techniques developed by
Kienstra et al describing intravascular injection of fluorescent
dextran into newborn mice [45]. Accordingly, we injected 50 mlo f
SE 1457 into the external jugular vein of each animal (Figure 1,
and Video S1). Each injection was scored and animals were
categorized by injections into acceptable (scores 3–5) and
unacceptable (scores 1 or 2) groups. To test the validity of the
scoring system, we euthanized animals at 2 h and harvested organs
to compare bacterial growth in spleen and liver homogenates.
Animals with injections scores in the acceptable group demon-
strated approximately 2–3 logs greater CFUs in spleen and liver,
validating our scoring system (Figure 2).
Inoculum-dependent infection of blood and solid organs
We next determined inoculum effects of SE infection on spleen,
liver and blood, comparing inocula of 10
6,1 0
7 and 10
8 CFU at
2 h post-injection (Figure 3). Only acceptable injection scores were
included in these analyses. We noted inoculum-dependent
infection, as indicated by greater CFUs, in each of these anatomic
compartments (Figure 3). No differences in mean CFUs were
noted when male and female newborns were compared (Figure
S1).
Clearance of SE bacteremia by neonatal mice within 24–
48 h of infection
To assess the course of SE infection in newborn mice, we
measured bacterial CFUs in spleen, liver and blood at 2, 24 and
48 h post-injection. Overall, there was a significant decrease in the
number of CFUs demonstrated by all organs and across all inocula
from 2 h to 48 h (p,0.001) (Figure 4). This suggests a natural
ability of newborn mice to gradually clear SE infection. Of note,
no mortality was observed during this 48 h post-injection period.
SE infection triggers activation of a TLR transcriptome in
liver
To assess the impact of SE infection on transcription of innate
immunity-related genes, we harvested livers 2 h post SE injection,
isolated RNA and analyzed it by qRT-PCR using TLR signaling
pathway gene arrays (Table S1). SE induced inoculum-dependent
increases in mRNA transcripts encoding multiple innate immune
genes, cytokines, and chemokines (Figure 5 and Table 3). Among
the transcripts significantly increased after injection of 10
8 CFU
were pattern-recognition receptors (TLR2, CD14), adaptor
molecules (MyD88, FADD), transcription factors (IP3, IRF-1,
Table 1. Technique diagram for intra-jugular injection of newborn mice.
Step Description
1 Person 1 holds pup and monitors for signs of distress
2 Person 1 pushes mouse right forelimb down with thumb and uses index finger to pull head back in order to extend neck and expose the external jugular
vein
3 Person 2 approaches the external jugular at a 10–20 degree angle and inserts needle bevel down
4 Person 2 then administers injection of 50 ul of inoculum at desired concentration (slowly) and pulls out
5 Person 1 provides gentle pressure for hemostasis, marks pup for identification and replaces pup in cage
6 Person 1 and 2 determine injection score based on scoring table
doi:10.1371/journal.pone.0043897.t001
Table 2. Injection scoring criteria.
Score Definition
1 Extravasation of inoculum into soft tissue (no blood seen on needle extraction)
2 Knicking of the vessel but inoculum mostly in the soft tissue (mostly inoculum seen on needle extraction)
3 Inoculum injected mostly into the vessel with some bubbling of surrounding soft tissue (blood and inoculum seen on needle extraction)
4 Inoculum injected mostly into the vessel with minimal bubbling of surrounding soft tissue (blood and inoculum seen on needle extraction)
5 Inoculum injected within the vessel (blood seen on extraction of needle with no soft tissue swelling)
doi:10.1371/journal.pone.0043897.t002
Neonatal Mouse Model of IV SE Infection
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2 [GM-CSF]). When data were analyzed as a function of inocula,
SE injection with 10
7 and 10
8 CFU resulted in the selective up-
regulation of TLR2 (p,0.05, Figure 6), but not any of the other
Figure 3. SE-induced inoculum-dependent infection of solid
organs and blood. Bacterial load in A) spleen, B) liver, and C) blood at
2 h following intra-jugular injection of SE at 10
6,1 0
7, and 10
8 CFU
showing inoculum-dependent increase in bacterial counts. Graph
represents individual data points with median values indicated by a
horizontal line. Only mice with injection scores of 3–5 were used in
analysis. Groups were compared using the Mann-Whitney t-test (N=7–
31, * p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0043897.g003
Figure 4. Neonatal mice clear SE infection within 48 h post-
injection. Effect of time on bacterial load in A) spleen, B) liver, and C)
blood following intra-jugular injection of SE at 10
6,1 0
7, and 10
8 CFU
shows significant clearance of bacteria by 48 h when compared to
inoculation at 2 h (N=5–31, ** p24 h,0.01, *** p24 h,0.001,
++p48 h,0.01, +++p48 h,0.001, Mann-Whitney t-test).
doi:10.1371/journal.pone.0043897.g004
Neonatal Mouse Model of IV SE Infection
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increased after SE injection (p,0.05, Figure 5). MyD88, a key
TLR adaptor molecule, was also up-regulated in response to the
10
8 inoculum (p,0.05, Figure 6).
SE infection triggers a high ratio of systemic IL-6/TNF-a
production
To confirm protein level expression of key cytokines and to
assess the relation of our model to known patterns of human
neonatal cytokine expression, we measured concentrations of IL-6
and TNF-a in plasma by ELISA (Figure 7). SE induced inoculum-
dependent production of both cytokines with IL-6 being induced
with greater potency and magnitude than TNF-a, a pattern
typically seen in human newborns with Gram-positive bacteremia
[2]. Additionally, multiplex cytokine analysis suggested SE-
induced production of multiple additional cytokines including
the neutrophil chemoattractant KC (CXCL1), colony-stimulating
factors GM-CSF (CSF-2) and G-CSF (CSF-3), and the anti-
inflammatory cytokine IL-10 (Figure 8).
SE infection results in inoculum-dependent impairment
in neonatal weight gain
Though newborn mice rapidly clear SE infection, exposure to
SE can trigger systemic inflammation with potentially pathologic
effects. We therefore measured weight as a sensitive marker of
neonatal well-being following SE injection. When normalized to
each animal’s birth weight, weight gain at both 24 and 48 h was
Figure 6. SE induces selective mRNA expression of TLR2 and
MyD88. Liver samples were collected 2 h post-SE injection and
analyzed for mRNA expression of TLR2, TLR4, MyD88, and MD-2.
Relative fold change in mRNA transcripts, each normalized to
housekeeping genes as described in methods, was expressed as a
ratio of each transcript in the SE injected animals to that in saline-
injected animals. SE induced significant inoculum-dependent increases
in mRNAs encoding TLR2 and MyD88 (* p,0.05, Student t-test). By
contrast, TLR4 and MD-2 were not up-regulated over saline-injected
mice.
doi:10.1371/journal.pone.0043897.g006
Figure 5. SE inoculum-dependent transcription of TLR signal-
ing pathway genes. Neonatal mice were injected IV with SE at A) 10
6,
B) 10
7, and C) 10
8 CFU and euthanized at 2 h. Liver tissue was
harvested, RNA isolated and transcription of TLR-signaling pathway
genes assessed. Log10 normalized gene expression levels are shown for
both saline (x-axis) and inoculum SE (y-axis) injected mice. Inoculum-
dependent up-regulation of TLR-gene transcription is evident, with
mRNA transcripts that are significantly up- or down-regulated shown in
red.
doi:10.1371/journal.pone.0043897.g005
Neonatal Mouse Model of IV SE Infection
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8 CFU
(p24 h,0.001, p48 h,0.05, Figure 9).
Discussion
Our study has established, for the first time, a neonatal model of
IV SE infection in mice less than 24 h old. This model uses a
clinically relevant age group and route of infection to study early
neonatal host-pathogen interactions and mechanisms of host
defense to SE. A prospectively validated injection scoring system
permits its use as a standard operating procedure. Our model
demonstrates inoculum-dependent infection of solid organs and
blood, activation of innate immune responses, bacterial clearance
by 24 to 48 h post-infection, and impairment of neonatal weight
gain. These features make this neonatal mouse model a useful tool
to study host and pathogen determinants of infection.
There are several parallels between mice and humans that
contribute to our model’s utility for evaluating neonatal SE
infection. Similar to human newborns who are able to clear SE
bacteremia within days, neonatal mice cleared SE from blood and
organs within 24 to 48 h of injection, demonstrating a natural
ability to overcome infection [47]. Clearance of SE bacteremia
was also associated with early activation of innate immune
responses. In particular, SE induced inoculum-dependent mRNA
transcription in the liver with increased expression of important
cytokines such as IL-6, an acute phase reactant known to be up-
regulated in infected human newborns [2,7,8,47]. SE-injected
mice also demonstrated selective increases in liver mRNA
encoding TLR2, a key innate immune receptor that mediates
recognition and clearance of multiple Gram-positive organisms
including SE [20,48,49,50,51], and of the TLR adaptor molecule,
MyD88 [52]. Interestingly, transcription of TLR2 and MyD88 are
both coordinately up-regulated during human neonatal Gram-
positive infection in vivo [53,54], highlighting how our murine
model recapitulates the human neonatal response to Gram-
Table 3. Changes in liver mRNA regulation 2 h following injection with 10
8 SE relative to control.
Up Regulation P Value No Change P Value No Change P Value Down Regulation P Value
Cxcl10 96.32 0.073 Muc13 1.86 0.105 Tradd 21.34 0.315 Ppara 22.25 *0.040
Ccl2 74.48 0.080 Il1r1 1.85 0.311 Nfrkb 21.35 0.355 Ly86 22.9 0.114
Csf3 72.03 0.143 Cd80 1.82 0.186 Irak1 21.36 0.488 Tlr8 23.33 *0.009
Tnfaip3 28.04 *0.027 Btk 1.53 0.373 Hspa1a 21.4 0.621
Ptgs2 18.93 0.136 Pglyrp1 1.47 0.232 Nr2c2 21.41 0.105
Tnf 17.65 0.114 Ticam2 1.46 0.307 Chuk 21.47 0.504
Tlr2 14.06 *0.044 Tlr4 1.45 0.425 Il6ra 21.48 0.372
Il10 13.36 *0.000 Irf3 1.33 0.785 Ly96 21.52 0.245
Clec4e 12.93 0.144 Nfkbil1 1.2 0.664 Tlr7 21.58 0.216
Cd14 12.17 *0.028 Ticam1 1.2 0.959 Tlr6 21.61 0.470
Il1b 11.87 *0.020 Tlr1 1.2 0.779 Tlr5 21.67 0.286
Ripk2 8.61 0.121 Hras1 1.19 0.378 Hmgb1 21.69 0.365
Irf1 8.44 *0.026 Tbk1 1.19 0.431 Casp8 21.71 0.648
Nfkb2 7.38 0.125 Mapk9 1.14 0.701 Mapk8 21.86 0.121
Myd88 6.5 *0.039 Eif2ak2 1.14 0.528 Hspd1 21.96 0.259
Nfkbia 6.32 *0.036 Tnfrsf1a 1.12 0.612
Il6 5.87 0.122 Elk1 1.11 0.759
Jun 5.15 *0.010 Tlr9 1.09 0.688
Csf2 4.62 *0.049 Traf6 1.08 0.952
Ifnb1 3.98 0.139 Ube2v1 1.07 0.644
Nfkb1 3.38 *0.020 Cd86 1.02 0.744
Rel 3.12 0.051 Map2k4 1.01 0.804
Cebpb 3.09 *0.018 Tollip 1 0.953
Il1a 2.92 0.080 Peli1 21.04 0.970
Ifng 2.55 0.125 Agfg1 21.05 0.956
Fos 2.45 0.357 Ikbkb 21.06 0.702
Fadd 2.41 *0.049 Tirap 21.14 0.766
Lta 2.3 0.179 Tlr3 21.2 0.987
Nfkbib 2.24 0.200 Map3k1 21.22 0.587
Il2 2.23 0.190 Mapk8ip3 21.22 0.582
Irak2 2.2 0.153 Map3k7 21.24 0.394
Rela 2.04 0.057 Map2k3 21.26 0.566
Il12a 2.02 0.161 Ube2n 21.29 0.890
doi:10.1371/journal.pone.0043897.t003
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impairment in weight gain, a sensitive marker of neonatal well-
being known to be negatively affected by infection in both mice
and human newborns [39,40]. Overall, these similarities suggest
that our model captures key characteristics of neonatal host-
bacterial interaction, highlighting its potential value.
A fundamental aspect of our model is its ability to demonstrate
the impact of inflammation following SE infection. Specifically,
impairment of weight gain likely reflects SE-induced inflamma-
tion, including systemic cytokine/chemokine induction. Our
model provides a venue to study additional effects of SE
bacteremia on neonatal physiology, including potential effects on
perinatal brain development and neurodevelopmental outcomes,
an area of increased biomedical focus [23,24,25,26,55,56].
In conclusion, we have established and prospectively validated a
neonatal model of IV SE infection in mice less than 24 h old. This
model demonstrates inoculum-dependent blood and solid organ
infection associated with innate immune activation as indicated by
selective induction of TLR-signaling pathway genes and corre-
sponding systemic cytokine production. Though the systemic
Figure 7. SE-induced systemic IL-6 and TNF-a production. IL-6
and TNF-a were both up-regulated in response to intra-jugular injection
with SE showing a high ratio of IL-6 to TNF-a at 2 h post-injection. IL-6
was induced in an inoculum-dependent manner following injection
with 10
6,1 0
7 and 10
8 CFUs. TNF-a was also induced, but at substantially
lower concentrations, with significance only at the highest inoculum
when compared to saline injections (N=4–9, * p,0.05, ** p,0.01,
*** p,0.001, Mann-Whitney t-test).
doi:10.1371/journal.pone.0043897.g007
Figure 8. SE induced systemic cytokine production. Radar plot representation of Milliplex cytokine data that highlights the fold change in
cytokine induction demonstrating up-regulation of both IL-6 and TNF-a in mice injected with 10
8 CFU of SE at 2 h. Results represent 3 independent
experiments.
doi:10.1371/journal.pone.0043897.g008
Figure 9. SE inoculum-dependent impairment of neonatal
weight gain. Newborn pups were weighed at birth (birth
weight=BW) and at 24 and 48 h following injection with saline or
the indicated inocula of SE. There was significant impairment of weight
gain noted in mice injected with 10
8 CFU of SE. This pattern of growth
was observed at both 24 and 48 h (N=5–13, * p,0.05, *** p,0.001,
Mann-Whitney t-test).
doi:10.1371/journal.pone.0043897.g009
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PLOS ONE | www.plosone.org 8 September 2012 | Volume 7 | Issue 9 | e43897cytokine response is associated with bacterial clearance, it also
likely contributes to impairment of weight gain reflecting
downstream effects of inflammation. Long-term evaluation and
treatment of septic neonates will need to focus on balancing
inflammation and bacterial killing. To this end, our model will
enable mechanistic studies of host-pathogen interactions and
development of novel diagnostics and therapeutics.
Supporting Information
Figure S1 Comparison of bacterial burden in solid
organs of female and male mice. Neonatal pups were
injected with 10
8 CFU of SE and euthanized at 2 h for harvest of
spleen and liver. Organ homogenates were plated for bacterial
CFU. Pup tissue was genotyped using real time PCR. Mean CFUs
were similar for female and male pups (N=3–7, Mann-Whitney t-
test).
(PDF)
Video S1 Intra-jugular injection in newborn mice. Video
illustrates the necessary steps for performing accurate intra-jugular
injection in newborn mice (injection sore 4). These steps are
further described in table 1.
(M4V)
Table S1 Summary of gene products used in the mouse
TLR signaling array.
(PDF)
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